133 related articles for article (PubMed ID: 31706846)
1. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
Chovancova B; Liskova V; Miklikova S; Hudecova S; Babula P; Penesova A; Sevcikova A; Durinikova E; Novakova M; Matuskova M; Krizanova O
Biochem Pharmacol; 2020 Jan; 171():113695. PubMed ID: 31706846
[TBL] [Abstract][Full Text] [Related]
2. Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells.
Rezuchova I; Hudecova S; Soltysova A; Matuskova M; Durinikova E; Chovancova B; Zuzcak M; Cihova M; Burikova M; Penesova A; Lencesova L; Breza J; Krizanova O
Cell Death Dis; 2019 Feb; 10(3):186. PubMed ID: 30796197
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells.
Endo Y; Lyon S; Shen Y; Mohan N; Wu WJ
Sci Rep; 2019 Nov; 9(1):16383. PubMed ID: 31704984
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine attenuated TNF-α-induced intracellular Ca
Zhao M; Jia HH; Liu LZ; Bi XY; Xu M; Yu XJ; He X; Zang WJ
J Mol Cell Cardiol; 2017 Jun; 107():1-12. PubMed ID: 28395930
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine promotes the proliferation and migration of breast cancer cells.
Guo DQ; Zhang H; Tan SJ; Gu YC
PLoS One; 2014; 9(12):e113649. PubMed ID: 25436889
[TBL] [Abstract][Full Text] [Related]
6. Sodium/calcium exchanger is involved in apoptosis induced by H
Szadvari I; Hudecova S; Chovancova B; Matuskova M; Cholujova D; Lencesova L; Valerian D; Ondrias K; Babula P; Krizanova O
Nitric Oxide; 2019 Jun; 87():1-9. PubMed ID: 30849492
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
Natarajan S; Ranganathan M
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
[TBL] [Abstract][Full Text] [Related]
8. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
10. Melatonin-Induced Changes in Cytosolic Calcium Might be Responsible for Apoptosis Induction in Tumour Cells.
Chovancova B; Hudecova S; Lencesova L; Babula P; Rezuchova I; Penesova A; Grman M; Moravcik R; Zeman M; Krizanova O
Cell Physiol Biochem; 2017; 44(2):763-777. PubMed ID: 29169174
[TBL] [Abstract][Full Text] [Related]
11. CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells.
Xiong L; Ding L; Ning H; Wu C; Fu K; Wang Y; Zhang Y; Liu Y; Zhou L
Oncotarget; 2016 Sep; 7(36):57737-57751. PubMed ID: 27363028
[TBL] [Abstract][Full Text] [Related]
12. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
[TBL] [Abstract][Full Text] [Related]
13. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.
Moradi M; Gholipour H; Sepehri H; Attari F; Delphi L; Arefian E; Moridi Farimani M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2145-2156. PubMed ID: 32617603
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer.
Merry CR; McMahon S; Forrest ME; Bartels CF; Saiakhova A; Bartel CA; Scacheri PC; Thompson CL; Jackson MW; Harris LN; Khalil AM
Oncotarget; 2016 Aug; 7(33):53230-53244. PubMed ID: 27449296
[TBL] [Abstract][Full Text] [Related]
16. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.
Abdullah ML; Hafez MM; Al-Hoshani A; Al-Shabanah O
BMC Complement Altern Med; 2018 Dec; 18(1):321. PubMed ID: 30518369
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
18. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells.
Khandelwal S; Boylan M; Spallholz JE; Gollahon L
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373175
[TBL] [Abstract][Full Text] [Related]
20. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
